Ipsen SA (IPSEY-OTC) Stock Predictions - Stockchase
WATCH LIST
1
Ipsen SA (IPSEY-OTC)

ON STOCKCHASE SINCE Feb 2019

0

Ipsen SA

IPSEY-OTC

4 watching          
Join the Discussion

Ipsen SA (IPSEY-OTC) SAVE Apr, 19, 2019, 9:05 am

33.19 1.16 (3.38%)

About Ipsen SA (IPSEY-OTC)

Ipsen is a French pharmaceutical company headquartered in Paris, France. It develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products. It is publicly traded on the Euronext Paris as part of the SBF 120 index. Ipsen has about 5,400 employees worldwide. More at Wikipedia

What the experts are saying about IPSEY-OTC



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Ipsen SA(IPSEY-OTC) 

February 15, 2019

Targetting oncology mostly. Small cap. Growing at a rapid rate. Debt to EBITDA is only 2x. Spending 13% of revenues on R&D, which is pretty hefty. (Analysts’ price target is $143.07)
0 0 0 0 0
0 comments
Targetting oncology mostly. Small cap. Growing at a rapid rate. Debt to EBITDA is only 2x. Spending 13% of revenues on R&D, which is pretty hefty. (Analysts’ price target is $143.07)
0
0 0 0 0 0
0 comments
David Driscoll

President , Liberty Internationa...

Price Price
$35.100
Owned Owned
Yes

Showing 1 to 1 of 1 entries
Successfully Saved Company
Successfully Saved Company